Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Klerfalk Pharma AB

Closing information (x1000 NOK)

Closing information 2024/12 2023/12 2022/12
Turnover 802 More Arrow 1,083 Less Arrow 1,077
Financial expenses 269 More Arrow 3,007 Less Arrow 508
Earnings before taxes -216 More Arrow 173 Less Arrow -324
EBITDA -147 More Arrow 75 More Arrow 163
Total assets 11,703 More Arrow 11,859 Less Arrow 11,007
Current assets 415 More Arrow 673 More Arrow 1,149
Current liabilities 226 More Arrow 373 More Arrow 444
Equity capital 11,395 Less Arrow 11,374 Less Arrow 10,447
- share capital 52 Less Arrow 51 Less Arrow 47
Employees (average) 1 Equal arrow 1 Equal arrow 1

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 97.4% Less Arrow 95.9% Less Arrow 94.9%
Turnover per employee 802 More Arrow 1,083 Less Arrow 1,077
Profit as a percentage of turnover -26.9% More Arrow 16.0% Less Arrow -30.1%
Return on assets (ROA) 0.5% More Arrow 26.8% Less Arrow 1.7%
Current ratio 183.6% Less Arrow 180.4% More Arrow 258.8%
Return on equity (ROE) -1.9% More Arrow 1.5% Less Arrow -3.1%
Change turnover -300 More Arrow -71 Less Arrow -473
Change turnover % -27% More Arrow -6% Less Arrow -31%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees % 0% Equal arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.